Get alerts for new trials in your area by subscribing now
New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.
Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.
Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.
RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.
Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.
COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.
Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.
Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.
65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It
Most vaccine trials enroll healthy people, not patients, so the safety bar is especially high and the studies are large: proving a vaccine prevents illness means waiting for enough people in the placebo group to get sick. That is why late stage vaccine trials often enroll tens of thousands of people, why they are usually placebo controlled or compared with an existing vaccine, and why they track side effects closely for days after each dose and safety for months. Our guide explains how long vaccine trials take, and our placebo controlled trials guide covers what the comparison group receives.
Most preventive vaccine studies enroll healthy adults in a set age range, often 18 to 49 or 50 and older, without the infection in question and often without recent vaccination against it. Pregnancy vaccine studies enroll people in a specific window of pregnancy. Human challenge studies have the strictest rules, usually healthy adults 18 to 49 with no chronic conditions, and involve a stay at a research unit. Cancer vaccine studies, by contrast, enroll people with a specific cancer, often after surgery. Nearly all vaccine trials are randomized, so no one is promised the vaccine rather than the placebo or comparison vaccine. Eligibility always varies by study.
Considering volunteering in a clinical trial? Explore our comprehensive guide to learn more about why people choose to volunteer and the impact you can make in advancing medical research. Discover the process of volunteering, what to consider before applying and the potential benefits and risks involved.
Some studies offer compensation for time and travel, and study related visits and tests are typically provided at no cost to participants. Human challenge studies, which involve a stay at a research unit, are described in more detail on our healthy volunteers page. Compensation varies by trial and is always described during the informed consent process before you agree to anything.
Curious whether clinical trials pay participants? Here's how compensation actually works.
Enrolling in a clinical trial for vaccines through our platform is a straightforward and user-friendly process. Here's how to get started: